These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. FDA approves licensing of erenumab-aooe to prevent migraine. Traynor K Am J Health Syst Pharm; 2018 Jul; 75(13):929-930. PubMed ID: 29941531 [No Abstract] [Full Text] [Related]
10. Fresh from the biologic pipeline. Osborne R Nat Biotechnol; 2009 Mar; 27(3):222-5. PubMed ID: 19270664 [No Abstract] [Full Text] [Related]
11. Experimental use and the Orphan Drug Act: a biotechnology conundrum. Koivuniemi PJ Nat Biotechnol; 1996 Apr; 14(4):511-2. PubMed ID: 9630930 [No Abstract] [Full Text] [Related]
12. Monoclonal antibody successes in the clinic. Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394 [TBL] [Abstract][Full Text] [Related]
13. Barriers to biosimilar utilization in the United States. Dalpoas SE; Socal M; Proctor C; Shermock KM Am J Health Syst Pharm; 2020 Nov; 77(23):2006-2014. PubMed ID: 33091103 [No Abstract] [Full Text] [Related]
14. Monoclonal antibody: the corner stone of modern biotherapeutics. Xia ZN; Cai XT; Cao P Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138 [TBL] [Abstract][Full Text] [Related]
15. 1999 a disappointing year for biotech approvals. Piascik P J Am Pharm Assoc (Wash); 2000; 40(2):269-70. PubMed ID: 10730031 [No Abstract] [Full Text] [Related]
16. The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States. Nakayama H; Matsumaru N; Tsukamoto K Invest New Drugs; 2019 Oct; 37(5):1086-1093. PubMed ID: 29855823 [TBL] [Abstract][Full Text] [Related]
17. Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies. Li J; Florian J; Campbell E; Schrieber SJ; Bai JPF; Weaver JL; Hyland PL; Thway TM; Matta MK; Lankapalli RH; Narayanasamy S; Dancy J; Zusterzeel R; Tyson JY; Prentice KW; Jackson KC; Patel V; Rouse RL; Wang YC; Strauss DG Clin Pharmacol Ther; 2020 Jan; 107(1):40-42. PubMed ID: 31667825 [No Abstract] [Full Text] [Related]
18. First US biosimilar edges towards market. Senior M Nat Biotechnol; 2015 Mar; 33(3):222-3. PubMed ID: 25748898 [No Abstract] [Full Text] [Related]
19. Fresh from the biotech pipeline-2014. Morrison C Nat Biotechnol; 2015 Feb; 33(2):125-8. PubMed ID: 25658270 [No Abstract] [Full Text] [Related]